NATULAN procarbazine 50mg (as hydrochloride) capsule blister pack Australia - English - Department of Health (Therapeutic Goods Administration)

natulan procarbazine 50mg (as hydrochloride) capsule blister pack

link medical products pty ltd t/a link pharmaceuticals - procarbazine hydrochloride, quantity: 58.3 mg (equivalent: procarbazine, qty 50 mg) - capsule, hard - excipient ingredients: gelatin; iron oxide yellow; magnesium stearate; titanium dioxide; purified talc; mannitol; maize starch - indications as at 23 august 1991: treatment of hodgkin's disease (multiple lymphadenoma); treatment of other malignant lymphomas including lymphosarcoma, reticulosarcoma, brill-symmers disease. natulan is dissimilar to other cytostatic agents and may be effective in cases resistant to other drugs and x-rays.

ALACARE 5-aminolevulinic acid hydrochloride 8 mg dermal patch sachet Australia - English - Department of Health (Therapeutic Goods Administration)

alacare 5-aminolevulinic acid hydrochloride 8 mg dermal patch sachet

link medical products pty ltd t/a link pharmaceuticals - aminolevulinic acid hydrochloride, quantity: 10.2 mg (equivalent: aminolevulinic acid, qty 8 mg) - patch, dermal - excipient ingredients: polyethylene terephthalate; polyethylene; aluminium; ethyl acetate; acrylic acid; 2-ethylhexyl acrylate; methyl acrylate; glycidyl methacrylate; 2,2'-azobisisobutyronitrile; hexane - treatment of mild to moderate actinic keratoses (ak) lesions on the face and scalp (hairless areas).

DAPSONE dapsone 100mg tablet bottle Australia - English - Department of Health (Therapeutic Goods Administration)

dapsone dapsone 100mg tablet bottle

link medical products pty ltd t/a link pharmaceuticals - dapsone, quantity: 100 mg - tablet, uncoated - excipient ingredients: maize starch; magnesium stearate; silicon dioxide; microcrystalline cellulose - dermatitis herpetiformis. leprosy. actinomycotic mycetoma.

DAPSONE dapsone 25mg tablet bottle Australia - English - Department of Health (Therapeutic Goods Administration)

dapsone dapsone 25mg tablet bottle

link medical products pty ltd t/a link pharmaceuticals - dapsone, quantity: 25 mg - tablet, uncoated - excipient ingredients: silicon dioxide; magnesium stearate; microcrystalline cellulose; maize starch - dermatitis herpetiformis. leprosy. actinomycotic mycetoma.

CHLOROMYCETIN SUCCINATE INJECTION Australia - English - Department of Health (Therapeutic Goods Administration)

chloromycetin succinate injection

link medical products pty ltd t/a link pharmaceuticals - chloramphenicol sodium succinate (equivalent: chloramphenicol, qty 1 g) - injection, powder for - excipient ingredients: - chloromycetin succinate is specifically indicated for bacterial meningitis, typhoid fever, rickettsial infections, intra ocular infections, other serious infections where bacteriological evidence or clinical judgement indicates that chloramphenicol is appropriate antibiotic.

FOSCAVIR foscarnet sodium 6g/250mL injection bottle Australia - English - Department of Health (Therapeutic Goods Administration)

foscavir foscarnet sodium 6g/250ml injection bottle

link medical products pty ltd t/a link pharmaceuticals - foscarnet sodium, quantity: 24 mg/ml - injection, solution - excipient ingredients: water for injections; hydrochloric acid - treatment of cytomegalovirus (cmv) retinitis in patients with the acquired immunodeficiency syndrome (aids). indications as at 11 november 1994: for treatment of cytomegalovirus (cmv) retinitis in patients with acquired immunodeficiency syndrome (aids); and treatment of aciclovir resistant herpes simplex virus (hsv) infections (defined by clinical trial or in-vitro resistance) in immunocompromised patients with human immunodeficiency virus (hiv) infection. note: the indication for treatment of aciclovir resistant hsv infections in immunocompromised patients with hiv infections is based primarily on the results of one open label comparative study. this was of patients with hiv infections and herpetic lesions unresponsive to aciclovir administered intravenously for 10 days or more and in-vitro documented resistance to aciclovir. eight patients were randomised to foscarnet (40mg/kg iv given eight hourly) and 6 were randomised to vidarabine 15mg/kg iv daily. the results showed a significant difference in favour o

AIR LIQUIDE AIR MEDICAL EP GRADE (medical air) air 100% v/v gas cylinder Australia - English - Department of Health (Therapeutic Goods Administration)

air liquide air medical ep grade (medical air) air 100% v/v gas cylinder

air liquide healthcare pty ltd - air, quantity: 100 % v/v - gas, medicinal - excipient ingredients: - for normal respiration. in anaesthetic equipment as a carrier gas during surgery. for nebulisation of inhaled drugs when oxygen supplementation is not required.

AT-Patch Medical Device United Arab Emirates - English - MOHAP (Ministry of Health & Prevention) - وزارة الصحة ووقاية المجتمع.الإمارات

at-patch medical device

al inmaa drug store & medical equipments llc korea (south) - 1 device unit (atp-c130) accessory kit (atacc-c130e) - device - medical device - medical devices-medical devices

Medical device disinfectant Australia - English - Department of Health (Therapeutic Goods Administration)

medical device disinfectant

whiteley corporation pty ltd t/a whiteley medical - 47631 - medical device disinfectant - instrumax pink is a low level instrument grade disinfectant for use on non-critical medical devices and environmental surfaces. not for use on skin. the device is effective against sars-cov-2 virus.